Sign In
Buy APRI
$1.03
+0 (+0%)
At Close: May 27, 2022
Aprinoia Therapeutics Starts $50 Million IPO For Neurodegenerative Disease Treatments
05:40pm, Friday, 02'nd Feb 2024
Aprinoia Therapeutics has filed for a $50 million IPO to develop diagnostics and therapeutics for neurodegenerative diseases. The company's lead therapeutic candidate is in Phase 1a trials for Alzheim
